| UNIASIAPACIFIC A | RVI ASIA EX-JAPÓN | 49,75% | 80,47% | 39,31% | 102,43% |
| INVESCO COMMODITY ALLOCATION C CAP USD | RVI MATERIAS PRIMAS | 49,73% | 139,27% | 131,14% | 126,55% |
| MAN JAPAN COREALPHA EQUITY I H GBP | RVI JAPÓN | 49,62% | 137,15% | 275,02% | 414,94% |
| NINETY ONE GSF GLOBAL NATURAL RESOURCES FUND A ACC USD | RVI MATERIAS PRIMAS | 49,61% | 73,87% | 143,49% | 248,08% |
| DWS INVEST II GLOBAL EQUITY HIGH CONVICTION LD | RVI GLOBAL | 49,59% | 93,69% | 104,45% | 251,46% |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 49,59% | 37,13% | -19,21% | · |
| NOMURA FUNDS IRELAND - ASIA EX JAPAN HIGH CONVICTION FUND A HKD | RVI ASIA EX-JAPÓN | 49,58% | · | · | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO S1 EUR | RVI TECNOLOGÍA | 49,54% | 141,78% | 100,80% | 685,99% |
| UBS (IRL) INVESTOR SELECTION - GLOBAL EMERGING MARKETS OPPORTUNITY (EUR) I-B-ACC | RVI EMERGENTES | 49,52% | 89,80% | 53,15% | 163,39% |
| RAIFFEISEN-ASIA-OPPORTUNITIES-ESG-AKTIEN (I) (VTA) | RVI EMERGENTES | 49,51% | 88,89% | 60,60% | 131,10% |
